Wakamoto’s Apr-Sep Profits Up 2% on Latanoprost Sales Growth, Recovered Losses

October 31, 2011
According to the consolidated settlement of accounts for the first half (April-September 2011) of FY2012 announced on October 28, Wakamoto Pharmaceutical posted sales of ¥4.737 billion (+ 2.1% compared to the corresponding period of the previous year), reflecting growth in...read more